$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

소아에서의 마이코플라스마 폐렴의 진단을 위한 항체 검사에 관한 연구
Indirect Particle Agglutination Antibody Testing for Early Diagnosis of Mycoplasma pneumoniae pneumonia in Children 원문보기

소아감염 = Korean journal of pediatric infectious diseases, v.20 no.2, 2013년, pp.71 - 80  

김진수 (한양대학교 의과대학 소아과학교실) ,  고정희 (한양대학교 의과대학 소아과학교실) ,  오성희 (한양대학교 의과대학 소아과학교실)

초록
AI-Helper 아이콘AI-Helper

목 적 : 이 연구의 목적은 항체 검사를 어느 시기에 검사해야 마이코플라스마 폐렴을 가장 적절하게 진단을 내릴 수 있는지를 파악하기 위함이다. 방 법 : 2011년 6월부터 2011년 10월까지의 한양대학교병원에서 진단받은 206 명의 폐렴 환아들을 대상으로 후향적으로 분석하였다. 결 과 : 마이코플라스마 폐렴으로 진단받은 160명의 평균 연령은 5.4세이었다. 마이코플라스마 간접입자 응집항체의 측정을 위한 혈청 획득 시간은 마이코플라스마 항체가가 1:640 이상인 혈청들과(8.58일) 1:640 미만인 혈청들(5.44일) 사이에서 통계학적으로 유의한 차이가 있었다(P<0.001). 결 론 : 본 연구의 결과는 폐렴 환아에서 증상 시작일로부터 8일 전에 획득한 마이코플라스마 항체가가 음성이면 확진을 위해 반복 검사가 필요한 것으로 보였다. 이 제안으로 마이코플라스마 폐렴에서 최적의 진단을 내릴 수 있게 도움을 줄 수 있을 것이다.

Abstract AI-Helper 아이콘AI-Helper

Objectives: Outbreaks of pneumonia caused by Mycoplasma pneumoniae (MP) occur every 3-4 years in Korea, most recently in 2011. The aim of our study was to determine the optimal time to perform indirect particle agglutination antibody assays to improve early diagnosis of MP pneumonia in children. Met...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

제안 방법

  • For one of the limitations of our study is its retrospective design, a prospective study with several cohorts, and MP antibody titers obtained at scheduled intervals could shed more light on the diagnostic performance of MP serological tests. Secondly, it is possible that the small number of patients without MP pneumonia may have contributed to the low specificity of the PCR and the MP antibody assays in our study (52.
  • In this study we examined the clinical and laboratory findings for a group of children diagnosed with pneumonia and tested for MP antibody at presentation with fever and respiratory symptoms. We investigated the application of indirect particle agglutination antibody testing in early diagnosis of MP pneumonia in Korean children.

대상 데이터

  • Characteristics of patients with MP pneumonia was diagnosed in 160 patients. Their mean age was 5.
  • Coinfected viruses were detected in the 54 patients (35.3%) with MP pneumonia patients. The percentage was higher than Kim et al.
  • Of the 206 pneumonia patients, 160 were diagnosed with MP pneumonia. Of these, 152 were inpatients, and eight were outpatients. MP pneumonia was diagnosed in 108 (67.
  • The study included 206 patients (196 inpatients and 10 outpatients) diagnosed with pneumonia and tested for MP by measuring indirect particle agglutination (MP) antibody titers from June to October 2011 at the department of Pediatrics, Hanyang University Hospital, Seoul, Korea. Pneumonia was defined as the presence of an infiltrate on chest x-ray, and respiratory symptoms including cough, difficulty breathing, tachypnea, and/or fever.

데이터처리

  • Time from the onset of pneumonia symptoms to specimen collection for testing was compared between patients with positive and negative MP antibody titers, and between patients with positive and negative MP PCR, using the Wilcoxon rank sum test. The mean antibody titers and the mean times from symptom onset to specimen collection were compared between the paired titers using the Wilcoxon signed rank test. The optimal time for MP antibody testing was estimated by performing receiver operating characteristic (ROC) analysis.
본문요약 정보가 도움이 되었나요?

참고문헌 (33)

  1. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993;17(Suppl. 1):S37-46. 

  2. Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50:543-7. 

  3. Ou ZY, Zhou R, Wang FH, Lu JP, Xia JQ, Xia HM, et al. Retrospective analysis of Mycoplasma pneumoniae infection in pediatric fatal pneumonia in Guangzhou, South China. Clin Pediatr 2008;47:791-6. 

  4. Madani TA, Al-Ghamdi AA. Clinical features of cultureproven Mycoplasma pneumoniae infections at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. BMC Infect Dis 2001;1:6. 

  5. Lind K, Benzon MW, Jensen JS, Clyde WA. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 1997;13:581-6. 

  6. Foy HM, Kenny GE, Cooney MK, Allan ID. Long-term epidemiology of infections with Mycoplasma pneumoniae. J Infect Dis 1979;139:681-7. 

  7. Ito I, Ishida T, Osawa M, Arita M, Hashimoto T, Hongo T, et al. Culturally verified Mycoplasma pneumoniae pneumonia in Japan: a long-term observation from 1979-99. Epidemiol Infect 2001;127:365-7. 

  8. Eun BW, Kim NH, Choi EH, Lee HJ. Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. J Infect 2008;56:326-31. 

  9. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 2004;17:697-728. 

  10. Mart nez MA, Ruiz M, Zunino i E, Luchsinger V, Avendano LF. Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. J Med Microbiol 2008;57:1491-5. 

  11. Zhang L, Zong ZY, Liu YB, Ye H, Lv XJ. PCR versus serology for diagnosing Mycoplasma pneumoniae infection: a systematic review & meta-analysis. Indian J Med Res 2011;134:270-80. 

  12. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainionpaa R, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 1998;36:3155-9. 

  13. Barker CE, Sillis M, Wreghitt TG. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mucapture ELISA and indirect immunofluorescence. J Clin Pathol 1990;43:163-5. 

  14. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis 1993;17(suppl 1):S79-82. 

  15. Loens K, Goossens H, Ieven M. Acute respiratory infection due to Mycoplasma pneumoniae: current status of diagnostic methods. Eur J Clin Microbiol Infect Dis 2010;29:1055-69. 

  16. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev 2008;32:956-73. 

  17. Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae. Expert Rev Anti Infect Ther 2008;6:509-21. 

  18. Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children. Korean J Pediatr 2012;55:42-7. 

  19. Nagayama Y, Sakurai N, Yamamoto K, Honda A, Makuta M, Suzuki R. Isolation of Mycoplasma pneumoniae from children with lower-respiratory-tract infections. J Infect Dis 1988;157:911-7. 

  20. Kim NH, Lee JA, Eun BW, Shin SH, Chung EH, Park KW, et al. Comparison of polymerase chain reaction and the indirect particle agglutination antibody test for the diagnosis of Mycoplasma pneumoniae pneumonia in children during two outbreaks. Pediatr Infect Dis 2007;26:897-903. 

  21. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, et al. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol 1973;98:289-300. 

  22. Carlsen KH, Orstavik I, Halvorsen K. Viral infections of the respiratory tract in hospitalized children. A study from Oslo during a 90 months'period. Acta Paediatr Scand 1983;72:53-8. 

  23. Foy HM, Grayston JT, Kenny GE, Alexander ER, Mc- Mahan R. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 1966;197:859-66. 

  24. Fernald GW, Collier AM, Clyde WA Jr. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 1975;55:327-35. 

  25. Alexander ER, Foy HM, Kenny GE, Kronmal RA, Mc- Mahan R, Clarke ER, et al. Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a cooperative medical group. N Engl J Med 1966;275:131-6. 

  26. Layani-Milon MP, Gras I, Valette M, Luciani J, Stagnara J, Aymard M, et al. Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rhone-Alpes, France, during five successive winter periods. J Clin Microbiol 1999;37:1721-6. 

  27. Principi N, Esposito S, Blasi F, Allegra L, Mowgli study group. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001;32:1281-9. 

  28. Kenny GE, Kaiser GG, Cooney MK, Foy HM. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J Clin Microbiol 1990;28:2087-93. 

  29. Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT, Baughman AL, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis 2009;48:1244-9. 

  30. Hong JY, Na SY, Nam SG, Choi EH, Park JY, Lee HJ. Occurrence of Mycoplasma pneumoniae pneumonia in Seoul, Korea, from 1986 to 1995. Korean J Pediatrics 1997;40:607-13. 

  31. Thacker WL, Talkington DF. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2000;7:778-80. 

  32. Dorigo-Zetsma JW, Zaat SA, Wertheim-van Dillen PM, Spanjaard L, Rijntjes J, van Waveren G, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol 1999;37:14-7. 

  33. Yu J, Yoo Y, Kim DK, Kang H, Koh YY. Distributions of antibody titers to Mycoplasma pneumoniae in Korean children in 2000-2003. J Korean Med Sci 2005;20:542-7 

저자의 다른 논문 :

관련 콘텐츠

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로